Item 9A. Controls and Procedures
Item
9A. Controls and Procedures.
Disclosure
Controls and Procedures
Evaluation of
Disclosure Controls and Procedures
Disclosure controls and procedures are
controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted
under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules
and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information
required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management,
including our Chief Executive Officer and Chief Financial Officer to allow timely decisions regarding required disclosure.
As required by Rules 13a-15 and 15d-15
under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness
of the design and operation of our disclosure controls and procedures as of December 31, 2020. Based upon their evaluations, our
Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules
13a-15(e) and 15d-15(e) under the Exchange Act) were effective.
Changes in Internal
Control over Financial Reporting
There was no change in our internal control
over financial reporting that occurred during the period from July 10, 2020 (inception), through December 31, 2020, covered by
this Annual Report on Form 10-K that has materially affected, or is reasonably likely to materially affect,
our internal control over financial reporting.
Internal Control
over Financial Reporting
This Annual Report on Form 10-K does not
include a report of management’s assessment regarding internal control over financial reporting or an attestation report
of our registered public accounting firm due to a transition period established by rules of the SEC for newly public companies.
During the most recently completed fiscal
year, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably
likely to materially affect, our internal control over financial reporting.
Item
9.B. Other Information.
None.
40
PART
III.
Item
10. Directors, Executive Officer and Corporate Governance.
Our current directors and executive officer
are as follows:
Name
Age
Title
Chamath Palihapitiya
44
Chief Executive Office and Chairman of the Board of Directors
Ian Osborne
37
President and Director
Steven Trieu
42
Chief Financial Officer
Simon Williams
40
General Counsel and Secretary
Jennifer Dulski
49
Director
Jay Parikh
47
Director
Chamath Palihapitiya has
been our Chief Executive Officer and the Chairman of our Board of Directors since July 2020. Mr. Palihapitiya founded
Social Capital in 2011 and has been its Managing Partner since its inception. Mr. Palihapitiya (1) served as the Chief
Executive Officer and the Chairman of the Board of Directors of IPOA from May 2017 until the consummation of its business
combination with Virgin Galactic in October 2019, and continues to serve as the Chairman of the Board of Directors of Virgin
Galactic, (2) served as the Chief Executive Officer and the Chairman of the Board of Directors of IPOB from October 2019 until
the consummation of its business combination with Opendoor 2019 and (3) served as the Chief Executive Officer and the Chairman
of the Board of Directors of IPOB from October 2019 until the consummation of its business combination with Clover Health. Mr. Palihapitiya
currently serves as Chief Executive Officer and Chairman of IPOD and IPOF. Mr. Palihapitiya also served as a director of Slack
Technologies Inc. from April 2014 until October 2019. Prior to founding Social Capital in 2011, Mr. Palihapitiya
served as Vice President of User Growth at Facebook, and is recognized as having been a major force in its launch and growth. Mr. Palihapitiya
was responsible for overseeing Monetization Products and Facebook Platform, both of which were key factors driving the increase
in Facebook’s user base to more than 750 million individuals worldwide. Prior to working for Facebook, Mr. Palihapitiya
was a principal at the Mayfield Fund, one of the United States’ oldest venture firms, before which he headed the instant
messaging division at AOL. Mr. Palihapitiya graduated from the University of Waterloo, Canada with a degree in electrical
engineering. Mr. Palihapitiya is well qualified to serve as the Chairperson of our board of directors because of his extensive
management history and experience in identifying, investing in and building next-generation technologies and companies.
Ian Osborne has been our
President and a member of our Board of Directors since July 2020. Mr. Osborne is the Co-founder and Chief Executive Officer
of Hedosophia, an investment firm, which has invested in leading Internet and technology companies since 2012. Mr. Osborne
served as President and a director of (1) IPOA from May 2017 until the consummation of its business combination with
Virgin Galactic in October 2019, (2) IPOB from January 2020 (October 2019 with respect to his director position) until the
consummation of its business combination with Opendoor and (3) IPOC from January 2020 (October 2019 with respect to his director
position) until the consummation of its business combination with Clover Health. Mr. Osborne currently serves as President
and a director of IPOD and IPOF. Mr. Osborne has advised leading Internet and technology companies, their founders and CEOs,
since 2009. Mr. Osborne is also the indirect controlling shareholder and a director of Connaught, a financial advisory firm.
From 2010 to 2012, Mr. Osborne was a Partner and Managing Director at DST Global, a family of funds investing in Internet
companies, which was established in 2009 and which has notable successes including Alibaba, Airbnb, Facebook, Spotify and Twitter.
Mr. Osborne was educated at St Paul’s School, King’s College London, and the London School of Economics. Mr. Osborne
is well qualified to serve on our board of directors because of his extensive experience advising leading Internet and technology
companies.
Steven Trieu has been
our Chief Financial Officer since July 2020. Mr. Trieu is a Partner and the Chief Financial Officer of Social
Capital, an affiliate of the company’s Sponsor, since October 2017 and is responsible for overseeing the
operations of Social Capital’s family of funds, management company and related entities. Mr. Trieu served as the
Chief Financial Officer of (1) IPOA from March 2019 until the consummation of its business combination with Virgin
Galactic in October 2019, (2) IPOB from January 2020 until the consummation of its business combination with Opendoor
and (3) IPOC from January 2020 until the consummation of its business combination with Clover Health. Mr. Trieu
currently serves as Chief Financial Officer of IPOD and IPOF. Prior to joining Social Capital, Mr. Trieu was VP of
Finance at Quora, Inc. from October 2011 to June 2016, where he was responsible for its day-to-day finance and
legal operations. Prior to that, Mr. Trieu was Director, Finance and Business Operations at Facebook, Inc. from
August 2007 to October 2011. Mr. Trieu led the formation of its initial business operations and sales finance
teams. Mr. Trieu also previously held a similar role at Yahoo!, Inc., supporting its local markets and commerce
divisions. Before that, Mr. Trieu spent time on Wall Street both as an investment banking and alternative investments
associate. Mr. Trieu graduated from the University of Massachusetts, Amherst with a degree in finance and
economics.
41
Simon Williams has been our
General Counsel and Secretary since July 2020. Mr. Williams has been Hedosophia’s Chief Administrative Officer
since March 2017. Mr. Williams served as the General Counsel and Secretary of (1) IPOA from May 2017 until
the consummation of its business combination with Virgin Galactic in October 2019, (2) IPOB from January 2020 until the consummation
of its business combination with Opendoor and (3) IPOC from January 2020 until the consummation of its business combination with
Clover Health. Mr. Williams currently serves as General Counsel and Secretary of IPOD and IPOF. Prior to joining Hedosophia,
Mr. Williams was legal counsel at Balderton Capital, a London-based venture firm focused on backing European-founded technology
companies, from January 2015 to March 2017. Prior to working at Balderton Capital, Mr. Williams was an associate
in the London offices of each of Covington & Burling LLP and Morrison & Foerster LLP. Mr. Williams is a solicitor,
qualified in England & Wales, having attended Nottingham Law School. Mr. Williams holds an MA and BA from the University
of Nottingham.
Jennifer Dulski has served
as one of our directors since November 2020. Ms. Dulski has a wide range of executive experience including executive leadership
roles at Facebook, Google and Yahoo!, and founder, CEO and president roles at early stage and scaling startups. She is currently
CEO and founder of Rising Team, a SaaS company that empowers managers to build more engaged and successful teams. Prior to Rising
Team, Ms. Dulski led Facebook Groups, used by more than 1.5 billion people each month to create and participate in communities
that matter to them. Her team was responsible for envisioning, building and growing the Groups product. Before Facebook, Ms. Dulski
was president & COO of Change.org, a social enterprise company that empowers people to create campaigns for change. Under her
leadership, Change.org grew 10x, to nearly 200m users, developed a profitable business model, rebuilt its tech stack and supported
thousands of successful campaigns globally. Prior to Change.org, Ms. Dulski was an early Yahoo! Employee and held a variety of
roles over 9 years there. She ultimately led one of the six core business units as group VP & GM of Local and Marketplaces.
Ms. Dulski left Yahoo! to become co-founder and CEO of The Dealmap, a location-based deals app that Google acquired in 2011, making
her the first woman entrepreneur to sell a company to Google. She was a product leader at Google for nearly 2 years before joining
Change. She currently serves on the boards of WW (formerly Weight Watchers), the Change.org Foundation and the Arctic Ice Project.
Her previous board experience includes roles on two other public company boards, Move, Inc. and TEGNA. Ms. Dulski is also a lecturer
in management at the Stanford Graduate School of Business and her first book, Purposeful, was published by Penguin Portfolio in
2018 and is a Wall Street Journal Bestseller.
Jay Parikh has served as
one of our directors since October 2020. Mr. Parikh has served as Head of Engineering at Facebook, Inc., since March 2014, supporting
and scaling tech teams across the company. From November 2009 to March 2020, Mr. Parikh served as Vice President, Infrastructure,
where he lead the global teams that design, develop, build, and operate the physical infrastructure and platforms (both software
and hardware) necessary to power Facebook and its family of products and services, enabling the community to grow from 300 million
users to over 3 billion users and providing users with their real-time experiences. From October 2007 to October 2009, Mr. Parikh
served as Senior Vice President, Engineering & Operations at Ning, Inc., where he oversaw product development, core infrastructure,
and operations for the company’s social networking platform. From April 1999 to October 2007, Mr. Parikh served as Vice President
of Engineering at Akamai Technologies, Inc., where he helped build one of the world’s largest and most globally distributed
computing platform. Mr. Parikh has served on the board of directors of Atlassian Corporation Plc since July 2013. Mr. Parikh received
his Bachelor of Science degree in mechanical engineering from Virginia Tech. Mr. Parikh is well qualified to serve on our board
of directors because of his extensive experience with technology and Internet companies and supporting and scaling businesses
Director Independence
The rules of the NYSE require that a
majority of our board of directors be independent within one year of our Initial Public Offering. An “independent
director” is defined generally as a person that, in the opinion of the company’s board of directors, has no
material relationship with the listed company (either directly or as a partner, shareholder or officer of an organization
that has a relationship with the company). We currently have two “independent directors” as defined in the NYSE
rules and applicable SEC rules. We expect a majority of our board of directors to be comprised of independent directors
within 12 months from the date of listing to comply with the majority independent board requirement. Our board has determined
that each of Ms. Dulski and Mr. Parikh is an independent director under applicable SEC and NYSE rules.
42
Number, Terms
of Office and Election of Officers and Directors
Our board of directors consists of four
members. Prior to our initial Business Combination, holders of our founder shares will have the right to appoint all of our directors
and remove members of the board of directors for any reason, and holders of our public shares will not have the right to vote on
the appointment of directors during such time. These provisions of our amended and restated memorandum and articles of association
may only be amended by a special resolution passed by the holders of a majority of at least 90% of our ordinary shares attending
and voting in a general meeting. Each of our directors will hold office for a two-year term. Subject to any other special rights
applicable to the shareholders, any vacancies on our board of directors may be filled by the affirmative vote of a majority of
the directors present and voting at the meeting of our board of directors or by a majority of the holders of our ordinary shares
(or, prior to our initial Business Combination, holders of our founder shares).
Our officers are appointed by the board
of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors
is authorized to appoint persons to the offices set forth in our amended and restated memorandum and articles of association as
it deems appropriate. Our amended and restated memorandum and articles of association provide that our officers may consist of
a Chairman, a Chief Executive Officer, a President, a Chief Operating Officer, a Chief Financial Officer, Vice Presidents, a Secretary,
Assistant Secretaries, a Treasurer and such other offices as may be determined by the board of directors.
Committees of the Board of Directors
Our board of directors has three standing
committees: an audit committee; a compensation committee; and a nominating and corporate governance committee. Each of our audit
committee, compensation committee and nominating and corporate governance committee are comprised solely of independent directors.
Each committee operates under a charter that was approved by our board of directors and has the composition and responsibilities
described below. The charter of each committee is available on our website.
Audit Committee
The members of our audit committee are
Ms. Dulski and Mr. Parikh. Mr. Parikh serves as chair of the audit committee. We will appoint a third qualifying member to our
audit committee within one year from the date of listing to comply with the audit committee requirement.
Each member of the audit committee is financially
literate and our board of directors has determined that Mr. Parikh qualifies as an “audit committee financial expert”
as defined in applicable SEC rules and has accounting or related financial management expertise.
We have adopted an audit committee charter,
which details the purpose and principal functions of the audit committee, including:
· assisting board oversight of (1) the integrity of our financial statements, (2) our compliance
with legal and regulatory requirements, (3) our independent auditor’s qualifications and independence, and (4) the
performance of our internal audit function and independent auditors;
· the appointment, compensation, retention, replacement, and oversight of the work of the independent
auditors and any other independent registered public accounting firm engaged by us;
· pre-approving all audit and non-audit services to be provided by the independent auditors or any
other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures;
43
· reviewing and discussing with the independent auditors all relationships the auditors have with
us in order to evaluate their continued independence;
· setting clear hiring policies for employees or former employees of the independent auditors;
· setting clear policies for audit partner rotation in compliance with applicable laws and regulations;
· obtaining and reviewing a report, at least annually, from the independent auditors describing (1) the
independent auditor’s internal quality-control procedures and (2) any material issues raised by the most recent internal
quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities,
within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal
with such issues;
· meeting to review and discuss our annual audited financial statements and quarterly financial statements
with management and the independent auditor, including reviewing our specific disclosures under “Item 7. Management’s
Discussion and Analysis of Financial Condition and Results of Operations”;
· reviewing and approving any related party transaction required to be disclosed pursuant to Item 404
of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and
· reviewing with management, the independent auditors, and our legal advisors, as appropriate, any
legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints
or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes
in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities.
Compensation Committee
The members of our compensation committee
are Ms. Dulski and Mr. Parikh. Mr. Parikh serves as chair of the compensation committee. We have adopted a compensation committee
charter, which details the purpose and responsibility of the compensation committee, including:
· reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief
Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives
and determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation;
· reviewing and making recommendations to our board of directors with respect to the compensation,
and any incentive-compensation and equity-based plans that are subject to board approval of all of our other officers;
· reviewing our executive compensation policies and plans;
· implementing and administering our incentive compensation equity-based remuneration plans;
· assisting management in complying with our proxy statement and annual report disclosure requirements;
· approving all special perquisites, special cash payments and other special compensation and benefit
arrangements for our officers and employees;
· producing a report on executive compensation to be included in our annual proxy statement; and
· reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors.
The charter also provides that the
compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, independent
legal counsel or other adviser and is directly responsible for the appointment, compensation and oversight of the work of any
such adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any
other adviser, the compensation committee will consider the independence of each such adviser, including the factors required
by the NYSE and the SEC.
44
Nominating and Corporate Governance
Committee
The members of our nominating and corporate
governance committee are Ms. Dulski and Mr. Parikh. Mr. Parikh serves as chair of the nominating and corporate governance committee.
We have adopted a nominating and corporate governance committee charter, which details the purpose and responsibilities of the
nominating and corporate governance committee, including:
· identifying, screening and reviewing individuals qualified to serve as directors, consistent with
criteria approved by the board of directors, and recommending to the board of directors candidates for nomination for appointment
at the annual general meeting or to fill vacancies on the board of directors;
· developing and recommending to the board of directors and overseeing implementation of our corporate
governance guidelines;
· coordinating and overseeing the annual self-evaluation of the board of directors, its committees,
individual directors and management in the governance of the company; and
· reviewing on a regular basis our overall corporate governance and recommending improvements as
and when necessary.
The charter also provides that the nominating
and corporate governance committee may, in its sole discretion, retain or obtain the advice of, and terminate, any search firm
to be used to identify director candidates, and is directly responsible for approving the search firm’s fees and other retention
terms.
We have not formally established any specific,
minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating
nominees for director, the board of directors considers educational background, diversity of professional experience, knowledge
of our business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our
shareholders. Prior to our initial Business Combination, holders of our public shares will not have the right to recommend director
candidates for nomination to our board of directors.
Delinquent
Section 16(a) Reports
Section
16(a) of the Exchange Act requires our officers, directors and persons who beneficially own more than ten percent of our ordinary
shares to file reports of ownership and changes in ownership with the SEC. Based solely upon a review of such forms, we believe
that during the year ended December 31, 2020 there were no delinquent filers with the following exception: each of our Sponsor,
ChaChaCha SPAC F, LLC and Mssrs. Palihapitiya, Osborne, Trieu, Williams and Parikh failed to file a Form 3 on the effective date
of the registration statement first registering our securities under Section 12 of the Exchange Act and were instead such forms
were filed on the next day.
Code of Ethics
We have adopted a code of ethics and business
conduct (our “Code of Ethics”) applicable to our directors, officers and employees. We have filed a copy of our Code
of Ethics as an exhibit to this Annual Report. We have also posted a copy of our Code of Ethics and the charters of our audit committee,
compensation committee and nominating and corporate governance committee on our website http://SocialCapitalHedosophiaHoldings.com/ipoe.html
under “Documents.” Our website and the information contained on, or that can be accessed through, the website is not
deemed to be incorporated by reference in, and is not considered part of, this Annual Report. You are able to review these documents
by accessing our public filings at the SEC’s website at www.sec.gov. In addition, a copy of the Code of Ethics will be provided
without charge upon request from us. We intend to disclose any amendments to or waivers of certain provisions of our Code of Ethics
in a Current Report on Form 8-K.
45
Conflicts of
Interest
Under Cayman Islands law, our directors
and officers owe the following fiduciary duties:
· duty to act in good faith in what the director or officer believes to be in the best interests
of the company as a whole;
· duty to exercise powers for the purposes for which those powers were conferred and not for a collateral
purpose;
· duty to not improperly fetter the exercise of future discretion;
· duty to exercise powers fairly as between different sections of shareholders;
· duty not to put themselves in a position in which there is a conflict between their duty to the
company and their personal interests; and
· duty to exercise independent judgment.
In addition to the above, directors also
owe a duty of care, which is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably diligent
person having both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same
functions as are carried out by that director in relation to the company and the general knowledge, skill and experience which
that director has.
As set out above, directors have a duty
not to put themselves in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit
as a result of their position. However, in some instances what would otherwise be a breach of this duty can be forgiven and/or
authorized in advance by the shareholders; provided that there is full disclosure by the directors. This can be done by way of
permission granted in the amended and restated memorandum and articles of association or alternatively by shareholder approval
at general meetings.
All of our officers and certain of our
directors have fiduciary and contractual duties to either Social Capital or Hedosophia and to certain companies in which either
of them has invested or are otherwise affiliated with. These entities, including the Other Existing SCH SPACs, may compete with
us for acquisition opportunities. If these entities decide to pursue any such opportunity, we may be precluded from pursuing such
opportunities. None of the members of our management team who are also employed by our Sponsor or its affiliates have any obligation
to present us with any opportunity for a potential Business Combination of which they become aware, subject to his or her fiduciary
duties under Cayman Islands law. Our Sponsor and directors and officers are also not prohibited from sponsoring, investing or otherwise
becoming involved with, any other blank check companies, including in connection with their initial Business Combinations, prior
to us completing our initial Business Combination, and any such involvement may result in conflicts of interests as described herein.
Our management team, in their capacities as directors, officers or employees of our Sponsor or its affiliates or in their other
endeavors (including other special purpose acquisition companies they are or may become involved with), may choose to present potential
Business Combinations to the related entities described above, current or future entities affiliated with or managed by our Sponsor,
or third parties, before they present such opportunities to us, subject to his or her fiduciary duties under Cayman Islands law
and any other applicable fiduciary duties.
Our directors and officers presently
have, and any of them in the future may have, additional, fiduciary or contractual obligations to other entities (including
other special purpose acquisition companies they are or may become involved with) pursuant to which such officer or director
is or will be required to present a Business Combination opportunity to such entity. Accordingly, if any of our directors or
officers becomes aware of a Business Combination opportunity that is suitable for an entity to which he or she has
then-current fiduciary or contractual obligations, he or she may need to honor these fiduciary or contractual obligations to
present such Business Combination opportunity to such entity, subject to his or her fiduciary duties under Cayman Islands
law. Our amended and restated memorandum and articles of association provide that we renounce our interest in any corporate
opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or
her capacity as a director or officer of the company and it is an opportunity that we are able to complete on a reasonable
basis. Our directors and officers are also not required to commit any specified amount of time to our affairs, and,
accordingly, will have conflicts of interest in allocating management time among various business activities, including
identifying potential Business Combinations and monitoring the related due diligence. See “Item 1A. Risk
Factors — Risks Relating to Our Management Team and Conflicts of Interest — Certain of our
directors and officers are now, and expect in the future to become, affiliated with entities engaged in business activities
similar to those intended to be conducted by us and, accordingly, may have conflicts of interest in determining to which
entity a particular business opportunity should be presented.”
46
We do not believe, however, that the fiduciary
duties or contractual obligations of our directors or officers will materially affect our ability to identify and pursue Business
Combination opportunities (if we do not consummate the proposed SoFi Business Combination) or complete our initial Business Combination,
including the proposed SoFi Business Combination. You should not rely on the historical record of our founders’ and management’s
performance as indicative of our future performance. See “Item 1A. Risk Factors — General Risk Factors — Past
performance by our management team and their respective affiliates may not be indicative of future performance of an investment
in the company.”
In addition, we have the following potential
conflicts of interest:
· None of our directors or officers is required to commit his or her full time to our affairs and,
accordingly, may have conflicts of interest in allocating his or her time among various business activities.
· In the course of their other business activities, our directors and officers may become aware of
investment and business opportunities that may be appropriate for presentation to us as well as the other entities with which they
are affiliated, including the Other Existing SCH SPACs. Our management may have conflicts of interest in determining to which entity
a particular business opportunity should be presented.
· Our initial shareholders, directors and officers have agreed to waive their redemption rights with
respect to any founder shares and public shares held by them in connection with the consummation of our initial Business Combination.
Additionally, our initial shareholders have agreed to waive their redemption rights with respect to their founder shares if we
fail to consummate our initial Business Combination within 24 months after the closing of the Initial Public Offering or during
any Extension Period. However, if our initial shareholders (or any of our directors, officers or affiliates) acquire public shares,
they will be entitled to liquidating distributions from the Trust Account with respect to such public shares if we fail to consummate
our initial Business Combination within the prescribed time frame. If we do not complete our initial Business Combination within
such applicable time period, the proceeds of the sale of the Private Placement Warrants held in the Trust Account will be used
to fund the redemption of our public shares, and the Private Placement Warrants will expire worthless. Pursuant to a letter agreement
that our initial shareholders, directors and officers have entered into with us, with certain limited exceptions, the founder shares
will not be transferable, assignable or salable by our initial shareholders until the earlier of: (1) one year after the completion
of our initial Business Combination; and (2) subsequent to our initial Business Combination (x) if the last reported
sale price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends,
rights issuances, consolidations, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within
any 30-trading day period commencing at least 150 days after our initial Business Combination or (y) the date on which
we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of our public
shareholders having the right to exchange their ordinary shares for cash, securities or other property. With certain limited exceptions,
the Private Placement Warrants and the ordinary shares underlying such warrants, will not be transferable, assignable or salable
by our Sponsor until 30 days after the completion of our initial Business Combination. Since our Sponsor and directors and
officers may directly or indirectly own ordinary shares and warrants, our directors and officers may have a conflict of interest
in determining whether a particular target business is an appropriate business with which to effectuate our initial Business Combination.
· Our directors and officers may negotiate employment or consulting agreements with a target business
in connection with a particular Business Combination. These agreements may provide for them to receive compensation following our
initial Business Combination and as a result, may cause them to have conflicts of interest in determining whether to proceed with
a particular Business Combination.
47
· Our directors and officers may have a conflict of interest with respect to evaluating a particular
Business Combination if the retention or resignation of any such directors and officers was included by a target business as a
condition to any agreement with respect to our initial Business Combination.
The conflicts described above may not be
resolved in our favor.
Accordingly, as a result of multiple business
affiliations, our directors and officers have similar legal obligations relating to presenting business opportunities meeting the
above-listed criteria to multiple entities. Below is a table summarizing the entities to which our directors, officers and director
nominees currently have fiduciary duties or contractual obligations that may pose a conflict of interest with us:
Individual
Entity
Entity’s Business
Affiliation
Chamath Palihapitiya
Social Capital (1)
Investment Firm
Founder and Chief Executive Officer
Virgin Galactic Holdings, Inc.
Aerospace Company
Chairman of the Board of Directors
Social Capital Hedosophia Holdings Corp. IV
Special Purpose Acquisition Company
Chief Executive Officer and Chairman of the Board of Directors
Social Capital Hedosophia Holdings Corp. VI
Special Purpose Acquisition Company
Chief Executive Officer and Chairman of the Board of Directors
Ian Osborne
Hedosophia Group Limited (2)
Investment Firm
Co-Founder and Chief Executive Officer
Social Capital Hedosophia Holdings Corp. IV
Special Purpose Acquisition Company
Director
Social Capital Hedosophia Holdings Corp. VI
Special Purpose Acquisition Company
Director
Steven Trieu
Social Capital (1)
Investment Firm
Partner and Chief Financial Officer
Social Capital Hedosophia Holdings Corp. IV
Special Purpose Acquisition Company
Chief Financial Officer
Social Capital Hedosophia Holdings Corp. VI
Special Purpose Acquisition Company
Chief Financial Officer
Simon Williams
Hedosophia Group Limited (3)
Investment Firm
Chief Administrative Officer
Social Capital Hedosophia Holdings Corp. IV
Special Purpose Acquisition Company
General Counsel and Secretary
Social Capital Hedosophia Holdings Corp. VI
Special Purpose Acquisition Company
General Counsel and Secretary
Jennifer Dulski
Rising Team
SaaS company
Chief Executive Officer and Founder
Jay Parikh
Facebook
Technology Company
Head of Engineering
(1) Includes Social Capital Holdings Inc. and certain of its funds and other affiliates including affiliated
portfolio companies.
(2) Includes certain other affiliates of Hedosophia Group Limited, including Connaught.
(3) Includes certain affiliates of Hedosophia Group Limited.
Accordingly, if any of the above
directors or officers become aware of a Business Combination opportunity which is suitable for any of the above entities (or
any other entity, including additional special purpose acquisition companies, they become involved with) to which he or she
has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations
to present such Business Combination opportunity to such entity, and only present it to us if such entity rejects the
opportunity, subject to his or her fiduciary duties under Cayman Islands law. Our amended and restated memorandum and
articles of association provide that we renounce our interest in any corporate opportunity offered to any director or officer
unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of the
company and it is an opportunity that we are able to complete on a reasonable basis. We do not believe, however, that any of
the foregoing fiduciary duties or contractual obligations will materially affect our ability to identify and pursue Business
Combination opportunities or complete our initial Business Combination.
48
We are not prohibited from pursuing an
initial Business Combination with a company that is affiliated with our Sponsor, directors or officers. In the event we seek to
complete our initial Business Combination with such a company, we, or a committee of independent and disinterested directors, would
obtain an opinion from an independent investment banking firm or another valuation or appraisal firm that regularly renders fairness
opinions on the type of target business we are seeking to acquire that such an initial Business Combination is fair to our company
from a financial point of view.
In addition, our Sponsor or any of its
affiliates may make additional investments in the company in connection with the initial Business Combination, although our Sponsor
and its affiliates have no obligation or current intention to do so. If our Sponsor or any of its affiliates elects to make additional
investments, such proposed investments could influence our Sponsor’s motivation to complete an initial Business Combination.
In the event that we submit our initial
Business Combination to our public shareholders for a vote, our initial shareholders, directors and officers have agreed, pursuant
to the terms of a letter agreement entered into with us, to vote any founder shares (and their permitted transferees will agree)
and public shares held by them in favor of our initial Business Combination.
Item
11. Executive Compensation.
None of our directors or officers have
received any cash compensation for services rendered to us. Commencing on the date that our securities were first listed on the
NYSE through the earlier of consummation of our initial Business Combination and our liquidation, we will pay an affiliate of our
Sponsor a total of $10,000 per month for office space, administrative and support services. Our Sponsor, directors and officers,
or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities
on our behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. Our
audit committee will review on a quarterly basis all payments that were made by us to our Sponsor, directors, officers or our or
any of their respective affiliates. In September 2020, our Sponsor transferred 100,000 founder shares to Jay Parikh, at their original
per-share purchase price. In November 2020, pursuant to a Director Restricted Stock Unit Award Agreement, dated November 13, 2020,
between the Company and Ms. Dulski, we granted 100,000 restricted stock units (“RSUs”) to Ms. Dulski, which grant is
contingent on both the consummation of our initial Business Combination and a shareholder approved equity plan. The RSUs will vest
upon the consummation of such initial Business Combination and represent 100,000 Class A ordinary shares of the Company that will
settle on a date we select in the year following the year in which such Business Combination occurs.
After the completion of our initial Business
Combination, directors or members of our management team who remain with us may be paid consulting, management or other compensation
from the combined company. All compensation will be fully disclosed to shareholders, to the extent then known, in the tender offer
materials or proxy solicitation materials furnished to our shareholders in connection with a proposed Business Combination. It
is unlikely the amount of such compensation will be known at the time, because the directors of the post-combination business will
be responsible for determining executive officer and director compensation. Any compensation to be paid to our officers after the
completion of our initial Business Combination will be determined by a compensation committee constituted solely by independent
directors.
We are not party to any agreements with
our directors and officers that provide for benefits upon termination of employment. The existence or terms of any such employment
or consulting arrangements may influence our management’s motivation in identifying or selecting a target business, and we
do not believe that the ability of our management to remain with us after the consummation of our initial Business Combination
should be a determining factor in our decision to proceed with any potential Business Combination.
49
Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
The following table sets forth information
regarding the beneficial ownership of our ordinary shares as of the date of March 15, 2021 with respect to our ordinary shares
held by:
· each person known by us to be the beneficial owner of more than 5% of our issued and outstanding
ordinary shares;
· each of our executive officers and directors; and
· all our executive officers and directors as a group.
Unless otherwise indicated, we believe
that all persons named in the table have sole voting and investment power with respect to all ordinary shares beneficially owned
by them. The following table does not reflect record or beneficial ownership of the Private Placement Warrants as these warrants
are not exercisable within 60 days of March 15, 2021.
Class A Ordinary Shares
Class B Ordinary Shares (1)
Beneficially
Owned
Approximate
Percentage
of Class A
Issued and
Outstanding
Ordinary
Shares
Beneficially
Owned
Approximate
Percentage
of
Issued and
Outstanding
Ordinary
Shares
Name and Address of Beneficial Owner (2)
SCH Sponsor V LLC (our Sponsor) (3)
—
—
20,025,000
19.9 %
Chamath Palihapitiya (3)
—
—
20,025,000
19.9 %
Ian Osborne (3)
—
—
20,025,000
19.9 %
Steven Trieu
—
—
—
—
Simon Williams
—
—
—
—
Jennifer Dulski
—
—
—
—
Jay Parikh
—
—
100,000
*
Empyrean Capital Partners, LP (4)
4,733,273
5.9 %
—
—
All directors and officers
as a group (6 individuals)
—
—
20,125,000
20.0 %
* Less
than one percent.
(1) Unless otherwise noted, the business address of each of the following entities or individuals is
c/o Social Capital Hedosophia Holdings Corp. V, 317 University Ave, Suite 200, Palo Alto, CA 94301.
(2) Class B ordinary shares will convert into Class A ordinary shares on a one-for-one basis, subject
to adjustment, as described in the section entitled “Description of Securities” in our prospectus filed with the SEC
pursuant to Rule 424(b)(4) (File No. 333-248915).
(3) SCH Sponsor V LLC, our Sponsor, is the record holder of the Class B ordinary shares reported
herein. Messrs. Palihapitiya and Osborne may be deemed to beneficially own shares held by our Sponsor by virtue of their shared
control over our Sponsor. Each of Messrs. Palihapitiya and Osborne disclaims beneficial ownership of our ordinary shares held by
our Sponsor.
(4) According to a Schedule 13G filed with the SEC on January 12, 2021, each of Empyrean Capital
Overseas Master Fund, Ltd., Empyrean Capital Partners, LP and Amos Meron share voting and dispositive power with regard to 4,733,273
Class A ordinary shares of the Company. The business address for each is c/o Empyrean Capital Partners, LP, 10250 Constellation
Boulevard, Suite 2950, Los Angeles, CA 90067.
Our initial shareholders beneficially own
20.0% of the issued and outstanding ordinary shares and have the right to elect all of our directors prior to our initial Business
Combination as a result of holding all of the founder shares.
50
Holders of our public shares will not have
the right to appoint any directors to our board of directors prior to our initial Business Combination. In addition, because of
their ownership block, our initial shareholders may be able to effectively influence the outcome of all other matters requiring
approval by our shareholders, including amendments to our amended and restated memorandum and articles of association and approval
of significant corporate transactions.
Item
13. Certain Relationships and Related Transactions, and Director Independence.
Founder Shares
On July 10, 2020, the Company issued one
ordinary share to the Sponsor for no consideration. On July 16, 2020, the Company cancelled the one share issued in July 2020 and
the Sponsor purchased 2,875,000 Founder Shares for an aggregate purchase price of $25,000. On September 17, 2020, the Company effected
a share capitalization resulting in the Sponsor holding an aggregate of 18,687,500 Founder Shares. On October 8, 2020, the Company
effected another share capitalization resulting in the Company’s initial shareholders holding an aggregate of 20,125,000
Founder Shares. The Founder Shares will automatically convert into Class A ordinary shares at the time of the completion of a Business
Combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustments.
The Founder Shares included an aggregate
of up to 2,625,000 shares that were subject to forfeiture by the Sponsor to the extent that the underwriter’s over-allotment
option was not exercised in full or in part, so that the number of Founder Shares would collectively represent 20% of the Company’s
issued and outstanding shares upon the completion of the Initial Public Offering. As a result of the underwriters’ election
to fully exercise their over-allotment option, no Founder Shares are currently subject to forfeiture.
The Sponsor has agreed, subject to limited
exceptions, not to transfer, assign or sell any of its Class B ordinary shares or Class A ordinary shares received upon conversion
thereof (together, “Founder Shares”) until the earlier of: (A) one year after the completion of a Business Combination
and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A ordinary shares equals or exceeds
$12.00 per share (as adjusted for share subdivisions, share dividends, rights issuances, consolidations, reorganizations, recapitalizations
and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination,
or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar
transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares
for cash, securities or other property.
Private Placement
Warrants
Simultaneously with the consummation of
the Initial Public Offering, and the exercise of the over-allotment option in full and the sale of the Private Placement Warrants,
we consummated a private placement of 8,000,000 Private Placement Warrants to our Sponsor at a price of $2.00 per Private Placement
Warrant, generating total proceeds of $16,000,000. Each Private Placement Warrant is exercisable for one Class A ordinary share
at a price of $11.50 per share, subject to adjustment. A portion of the proceeds from the sale of the Private Placement Warrants
was added to the net proceeds from the Initial Public Offering held in the Trust Account.
The Private Placement Warrants are identical
to the warrants sold as part of the Units in the Initial Public Offering except that, so long as they are held by the Sponsor or
its permitted transferees: (1) they will not be redeemable by us (except in certain redemption scenarios when the price per Class
A ordinary share equals or exceeds $10.00 (as adjusted)); (2) they (including the Class A ordinary shares issuable upon exercise
of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days
after the completion of our Business Combination; (3) they may be exercised by the holders on a cashless basis; and (4) they (including
the Class A ordinary Shares issuable upon exercise of these warrants) are entitled to registration rights.
If we do not complete an Initial Business
Combination within 24 months from the closing of the Initial Public Offering or during any Extension Period, the proceeds of the
sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of our public shares, subject
to the requirements of applicable law, and the Private Placement Warrants will expire worthless.
51
Registration
Rights
Pursuant to a registration rights agreement
entered into on October 8, 2020, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued
upon conversion of Working Capital Loans (as defined below) (and any Class A ordinary shares issuable upon the exercise of the
Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares)
will be entitled to registration rights requiring the Company to register such securities for resale (in the case of the Founder
Shares, only after conversion to the Company’s Class A ordinary shares). The holders of these securities will be entitled
to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition,
the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent
to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to
Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to
effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up
period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. In connection
with the SoFi Business Combination, the registration rights agreement will be amended and restated.
Financial Advisory
Fee
The underwriters agreed to reimburse the
Company for an amount equal to (1) 10% of the non-deferred underwriting commission payable to the underwriter, of which $1,400,000
was paid to Connaught (UK) Limited (“Connaught”) upon the closing of the Initial Public Offering, and (2) 20%
of the deferred underwriting commission payable to the underwriter, of which $5,635,000 will be paid to Connaught upon the closing
of the Business Combination.
Related Party
Notes and Advances
As
of October 14, 2020, the Sponsor paid for certain offering costs on behalf of the Company in connection with the Initial Public
Offering. The advances are non-interest bearing and due on demand. As of December 31, 2020, advances amounting to $5,000 were outstanding.
On
July 16, 2020, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Company borrowed an aggregate
principal amount of $300,000. The note was non-interest bearing and payable on the earlier of (i) June 30, 2020 and (ii) the completion
of the Initial Public Offering. This note was amended and restated on September 17, 2020 solely to increase the amount that could
be borrowed to an aggregate principal amount of $400,000. The borrowings outstanding under the note in the amount of $400,000 were
repaid upon the consummation of the Initial Public Offering on October 14, 2020.
On
January 11, 2021, the Company issued a promissory note to Sponsor (the “Promissory Note”), pursuant to which the Company
may borrow up to an aggregate principal amount of $2,500,000. The Promissory Note is non-interest bearing and payable on the earlier
of (i) October 14, 2022 and (ii) the completion of the Business Combination. At January 22, 2021, there was $1,330,000 outstanding
under the Promissory Note.
In order to finance transaction costs in
connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers
and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such
Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination,
without interest, or, at the lender’s discretion, up to $2,500,000 of notes may be converted upon completion of a Business
Combination into warrants at a price of $2.00 per warrant. Such warrants would be identical to the Private Placement Warrants.
In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account
to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.
Administrative Support Agreement
The Company entered into an agreement
whereby, commencing on October 8, 2020, the Company will pay an affiliate of the Sponsor up to $10,000 per month for office
space, administrative and support services. Upon completion of a Business Combination or its liquidation, the Company will
cease paying these monthly fees. For the period from July 10, 2020 (inception) through December 31, 2020, the Company
incurred $25,000, in fees for these services, of which such amount is included in accrued expenses in the accompanying
balance sheet.
52
Subscription
Agreements
Concurrently
with the execution of the Merger Agreement, we entered into Subscription Agreements with the Sponsor Related PIPE Investors, pursuant
to which the Sponsor Related PIPE Investors have subscribed for shares of SoFi Technologies common stock in connection with the
PIPE Investment. The Sponsor Related PIPE Investors are expected to fund $275,000,000 of the PIPE Investment, for which they will
receive 27,500,000 shares of SoFi Technologies common stock. Specifically, (i) ChaChaCha SPAC 5, LLC, an entity affiliated with
our Chairman and Chief Executive Officer Chamath Palihapitiya, subscribed for 13,100,000 shares of SoFi Technologies common stock,
(ii) Hedosophia Group Limited, an entity affiliated with our President and director Ian Osborne, subscribed for 13,100,000 shares
of SoFi Technologies common stock, (iii) The Steven Trieu Living Trust dtd 4.3.12, an entity affiliated with our Chief Financial
Officer Steven Trieu, subscribed for 240,000 shares of SoFi Technologies common stock, and (iv) individuals affiliated with our
Sponsor subscribed for the remaining 1,060,000 shares of SoFi Technologies common stock. The PIPE Investment will be consummated
substantially concurrently with the closing of the Business Combination.
Item
14. Principal Accounting Fees and Services.
Fees for professional services provided
by our independent registered public accounting firm for the last two fiscal years include:
For the period from July 10, 2020 (inception) through December 31, 2020
Audit Fees (1)
$ 103,000
Audit-Related Fees (2)
$
—
Tax Fees (3)
$
—
All Other Fees (4)
$
—
Total
$
103,000
(1) Audit Fees. Audit fees consist of fees billed for professional services rendered for the audit
of our year-end financial statements and services that are normally provided by our independent registered public accounting firm
in connection with statutory and regulatory filings.
(2) Audit-Related Fees. Audit-related fees consist of fees billed for assurance and related services
that are reasonably related to performance of the audit or review of our year-end financial statements and are not reported under
“Audit Fees.” These services include attest services that are not required by statute or regulation and consultation
concerning financial accounting and reporting standards.
(3) Tax Fees. Tax fees consist of fees billed for professional services relating to tax compliance,
tax planning and tax advice.
(4) All Other Fees. All other fees consist of fees billed for all other services including permitted
due diligence services related potential business combination.
Policy on Board
Pre-Approval of Audit and Permissible Non-Audit Services of the Independent Auditors
The audit committee is responsible for appointing,
setting compensation and overseeing the work of the independent auditors. In recognition of this responsibility, the audit committee
shall review and, in its sole discretion, pre-approve all audit and permitted non-audit services to be provided by the independent
auditors as provided under the audit committee charter.
53
PART
IV.
Item
15. Exhibits, Financial Statement Schedules.
(a) The following documents are filed as part of this Annual Report on Form 10-K: Financial Statements:
See “Item 8. Index to Financial Statements and Supplementary Data” herein.
(b) Exhibits: The exhibits listed in the accompanying index to exhibits are filed or incorporated by
reference as part of this Annual Report on Form 10-K.
No.
Description of Exhibit
3.1(1)
Amended and Restated Memorandum and Articles of Association of the Company.
4.1(1)
Warrant Agreement, dated October 8, 2020, between the Company and Continental Stock Transfer & Trust Company, as warrant agent.
4.2*
Description of the Company’s securities.
10.1(1)
Letter Agreement, dated October 8, 2020, among the Company, the Sponsor, the Company’s officers and directors and the other party thereto.
10.2(2)
Letter Agreement, dated November 13, 2020, between the Company and Jennifer Dulski.
10.3(1)
Investment Management Trust Agreement, dated October 8, 2020, between the Company and Continental Stock Transfer & Trust Company, as trustee.
10.4(1)
Registration Rights Agreement, dated October 8, 2020, between the Company and Continental Stock Transfer & Trust Company, as trustee.
10.5(1)
Administrative Services Agreement, dated October 8, 2020, between the Company and Social Capital Holdings, Inc.
10.6(1)
Sponsor Warrants Purchase Agreement, dated October 8, 2020, between the Company and the Sponsor.
10.7(1)
Indemnity Agreement, dated October 8, 2020, between the Company and Chamath Palihapitiya.
10.8(1)
Indemnity Agreement, dated October 8, 2020, between the Company and Ian Osborne.
10.9(1)
Indemnity Agreement, dated October 8, 2020, between the Company and Jay Parikh.
10.10(1)
Indemnity Agreement, dated October 8, 2020, between the Company and Steven Trieu.
10.11(1)
Indemnity Agreement, dated October 8, 2020, between the Company and Simon Williams.
10.12(2)
Indemnity Agreement, dated December 10, 2020, between the Company and Jennifer Dulski.
10.13(2)
Director Restricted Stock Unit Award Agreement, dated November 13, 2020, between the Company and Jennifer Dulski.
14.01*
Code of Ethics and Business Conduct of Social Capital Hedosophia Holdings Corp. V.
31.1*
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*
XBRL Instance Document.
101.SCH*
XBRL Taxonomy Extension Schema Document.
101.CAL*
XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*
XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*
XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*
XBRL Taxonomy Extension Presentation Linkbase Document.
* Filed herewith.
** Furnished herewith.
(1) Incorporated by reference to the Company’s Current Report on Form 8-K filed on October 14,
2020.
(2) Incorporated by reference to the Company’s Current Report on Form 8-K filed on November 16,
2020.
54
Item
16. Form 10-K Summary.
None.
55
SIGNATURES
Pursuant to the requirements of Section 13
or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
SOCIAL CAPITAL HEDOSOPHIA
HOLDINGS CORP. V
Date: March 17, 2021
/s/Chamath Palihapitiya
By:
Chamath Palihapitiya
Chief Executive Officer and
Chairman of the Board of Directors
Pursuant to the requirements of the Securities
Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities
and on the dates indicated.
/s/ Chamath Palihapitiya
Name:
Chamath Palihapitiya
Title:
Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer)
Date:
March 17, 2021
/s/ Ian Osborne
Name:
Ian Osborne
Title:
President and Director
Date:
March 17, 2021
/s/ Steve Trieu
Name:
Steve Trieu
Title:
Chief Financial Officer (Principal Financial and Accounting Officer)
Date:
March 17, 2021
/s/ Jennifer Dulski
Name:
Jennifer Dulski
Title:
Director
Date:
March 17, 2021
/s/ Jay Parikh
Name:
Jay Parikh
Title:
Director
Date:
March 17, 2021
56
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.